Frontiers in Neurology (Jun 2020)

A SCANO Nomogram for Individualized Prediction of the Probability of 1-Year Unfavorable Outcomes in Chinese Acute Ischemic Stroke Patients

  • Xiang Li,
  • Xiang Li,
  • Fusang Wang,
  • Fusang Wang,
  • Zhihong Zhao,
  • Chao Sun,
  • Chao Sun,
  • Jun Liao,
  • Xuemei Li,
  • Chaoping Huang,
  • Linda Nyame,
  • Linda Nyame,
  • Zheng Zhao,
  • Xiaohan Zheng,
  • Xiaohan Zheng,
  • Junshan Zhou,
  • Ming Li,
  • Jianjun Zou

DOI
https://doi.org/10.3389/fneur.2020.00531
Journal volume & issue
Vol. 11

Abstract

Read online

Background and Purpose: Accurate prediction of functional outcomes after stroke would provide evidence for reasonable poststroke management. This study aimed to develop and validate a nomogram for individualized prediction of 1-year unfavorable outcomes in Chinese acute ischemic stroke (AIS) patients.Methods: We gathered AIS patients at the National Advanced Stroke Center of Nanjing First Hospital (China) between August 2014 and May 2017 within 12 h of symptom onset. The outcome measure was 1-year unfavorable outcomes (modified Rankin Scale 3–6). The patients were randomly stratified into the training (66.7%) and testing (33.3%) sets. With the training data, pre-established predictors were entered into a logistic regression model to generate the nomogram. Predictive performance of the nomogram model was evaluated in the testing data by calculating the area under the receiver operating characteristic curve (AUC-ROC), Brier score, and a calibration plot.Results: A total of 807 patients were included into this study, and 262 (32.5%) of them had unfavorable outcomes. Systolic blood pressure, Creatinine, Age, National Institutes of Health Stroke Scale (NIHSS) score on admission, and fasting blood glucose were significantly associated with unfavorable outcomes and entered into the SCANO nomogram. The AUC-ROC of the SCANO nomogram in the testing set was 0.781 (Brier score: 0.166; calibration slope: 0.936; calibration intercept: 0.060).Conclusions: The SCANO nomogram is developed and validated in Chinese AIS patients to firstly predict 1-year unfavorable outcomes, which is simple and convenient for the management of stroke patients.

Keywords